University of Rhode Island

OrganizationRORWikidata

People

Sources: reporter.nih.gov

Trials

Sources: clinicaltrials.gov

Grants and prizes

  • National Institute of Allergy and Infectious Diseases

    R01, Multiantigen-based universal influenza vaccine development with a versatile VLP platform, R01AI192512, $2.3M, 2026–2030, Aug 20, 2026

  • National Institute on Aging

    R01, Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease, R01AG079241, $2M, 2022–2027, May 28, 2026

  • National Heart, Lung, and Blood Institute

    K01, Development of personalized healthy food incentives to improve diet and cardiovascular risk, K01HL165104, $173K, 2023–2028, May 27, 2026

  • National Institute on Aging

    R01, Tissue-Specific Modulation of mtDNA Mutations: Exploring Aging and Lifestyle Interventions, R01AG092603, $567K, 2026–2031, Jan 28, 2026

  • NIH Office of the Director

    R21, Novel Knock-in mtDNA Mouse Model to Study Mitochondrial Dysfunction, R21OD037651, $236K, 2024–2027, Jul 25, 2025

  • National Institute on Aging

    R21, Impact of ApoE in Novel Rat Models of Late-Onset AD, R21AG085087, $236K, 2024–2026, Nov 21, 2024

  • National Science Foundation

    Collaborative research: hcc: small: graph-centric exploration of nonlinear neural dynamics in visuospatial-motor functions during immersive human-computer interactions, 2417447, $350K, 2024–2027, Aug 28, 2024

  • National Institute on Minority Health and Health Disparities

    R01, Epigenomic mechanisms of risk and resilience: The role of parenting, R01MD015401, $358K, 2020–2026, Feb 20, 2024

  • National Institute of Nursing Research

    R01, Allostatic Load & Epigenetic Mechanisms in Lifecourse Trajectories of Premature Infants at Age 30, R01NR018147, $435K, 2019–2025, Mar 17, 2023

  • National Institute on Aging

    R00, The role of epigenetics in age-related cognitive decline and Alzheimer's disease, R00AG055683, $249K, 2017–2024, Jun 16, 2022

  • National Institute on Aging

    R21, Development of Retinal Biomarkers in Autosomal Dominant Alzheimer's Disease: A pilot study, R21AG074153, $459K, 2021–2024, Sep 21, 2021

  • National Institute on Aging

    R01, Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment, R01AG048935, $315K, 2015–2021, May 29, 2018

Sources: reporter.nih.gov, usaspending.gov

Funded papers

Sources: openalex.org, api.crossref.org

Papers